HK1181768A1 - Alkaloid aminoester derivatives and medicinal composition thereof - Google Patents

Alkaloid aminoester derivatives and medicinal composition thereof

Info

Publication number
HK1181768A1
HK1181768A1 HK13109177.1A HK13109177A HK1181768A1 HK 1181768 A1 HK1181768 A1 HK 1181768A1 HK 13109177 A HK13109177 A HK 13109177A HK 1181768 A1 HK1181768 A1 HK 1181768A1
Authority
HK
Hong Kong
Prior art keywords
medicinal composition
aminoester derivatives
alkaloid aminoester
alkaloid
derivatives
Prior art date
Application number
HK13109177.1A
Other languages
English (en)
Chinese (zh)
Inventor
．阿馬裡
．裡卡博尼
Original Assignee
奇斯藥製品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇斯藥製品公司 filed Critical 奇斯藥製品公司
Publication of HK1181768A1 publication Critical patent/HK1181768A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK13109177.1A 2010-06-22 2013-08-06 Alkaloid aminoester derivatives and medicinal composition thereof HK1181768A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10166894 2010-06-22
PCT/EP2011/058802 WO2011160919A1 (en) 2010-06-22 2011-05-30 Alkaloid aminoester derivatives and medicinal composition thereof

Publications (1)

Publication Number Publication Date
HK1181768A1 true HK1181768A1 (en) 2013-11-15

Family

ID=43301943

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13109177.1A HK1181768A1 (en) 2010-06-22 2013-08-06 Alkaloid aminoester derivatives and medicinal composition thereof

Country Status (10)

Country Link
US (1) US8563577B2 (xx)
EP (1) EP2585458B1 (xx)
KR (1) KR20130087406A (xx)
CN (1) CN102947299B (xx)
AR (1) AR081966A1 (xx)
BR (1) BR112012031967A2 (xx)
CA (1) CA2803433A1 (xx)
HK (1) HK1181768A1 (xx)
RU (1) RU2567548C2 (xx)
WO (1) WO2011160919A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2206712A1 (en) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
RU2569846C2 (ru) * 2010-06-22 2015-11-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Алкалоидные производные сложных аминоэфиров и включающие их лекарственные композиции
RU2585767C2 (ru) 2010-11-26 2016-06-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные глицина и их применение в качестве антагонистов мускариновых рецепторов
RU2628082C2 (ru) 2011-12-30 2017-08-14 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Хинуклидиновые эфиры 1-азагетероциклилуксусной кислоты в качестве антимускариновых средств, способ их получения и их лекарственные композиции
AR091655A1 (es) 2012-07-02 2015-02-18 Monsanto Technology Llc Procesos para la preparacion de 1,2,4-oxadiazoles 3,5-disustituidos
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
EP3229606A2 (en) 2014-12-10 2017-10-18 Mars, Incorporated Methods for modulating taste receptors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100869722B1 (ko) * 2000-12-22 2008-11-21 알미랄 에이쥐 퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
US6822073B2 (en) * 2001-12-20 2004-11-23 Kimberly-Clark Worldwide, Inc. Modular peptide-based reagent
JP4505227B2 (ja) 2001-12-20 2010-07-21 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ １−アルキル−１−アゾニアビシクロ［２．２．２］オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用
EP1882691A1 (en) 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Quinuclidine derivatives as M3 antagonists
KR20090094460A (ko) * 2006-12-19 2009-09-07 아스트라제네카 아베 무스카린 수용체 길항제로서 퀴누클리디놀 유도체
EP2154136A1 (en) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Quinuclidine carbonate derivatives and medicinal compositions thereof
EP2206712A1 (en) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"

Also Published As

Publication number Publication date
EP2585458A1 (en) 2013-05-01
CN102947299B (zh) 2015-07-15
RU2567548C2 (ru) 2015-11-10
RU2012155691A (ru) 2014-06-27
BR112012031967A2 (pt) 2019-09-24
US8563577B2 (en) 2013-10-22
CN102947299A (zh) 2013-02-27
US20110311459A1 (en) 2011-12-22
WO2011160919A1 (en) 2011-12-29
CA2803433A1 (en) 2011-12-29
AR081966A1 (es) 2012-10-31
EP2585458B1 (en) 2015-01-07
KR20130087406A (ko) 2013-08-06

Similar Documents

Publication Publication Date Title
HK1250313A1 (zh) 穩定的藥物組合物和使用所述組合物的方法
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
EP2604260A4 (en) NOVEL HETEROCYCLIC DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
HRP20181170T1 (hr) Novi derivat cefalosporina i njegov farmaceutski pripravak
HK1162174A1 (en) Alkaloid aminoester derivatives and medicinal composition thereof
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
HK1181768A1 (en) Alkaloid aminoester derivatives and medicinal composition thereof
AP3441A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
HK1183228A1 (zh) 口服藥物治療方法和組合物
HK1182093A1 (zh) 生物鹼氨基酯衍生物及其藥物組合物
ZA201108458B (en) Nitrile derivatives and their pharmaceutical use and compositions
HK1181047A1 (zh) 生物鹼氨基酯衍生物及其藥物組合物
IL223707A0 (en) N-hydroxyformamide derivative and medicament containing same
EP2529755A4 (en) PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220528